HBK Investments’s Guardant Health GH Stock Holding History

HBK Investments’s Portfolio GH Stock Details GH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q2	–	Sell	-36,403	Closed	-$2.79M	–	779
2019 Q1	$2.79M	Buy	+36,403	New	+$2.02M	0.03%	435

Other funds holding GH

SIAU

SB Investment Advisers (UK) London, United Kingdom $7.73B AUM 2.35% 1-Year Est. Return

SUT

SC US (TTGP) Menlo Park, California $9.25B AUM 20.49% 1-Year Est. Return

VK Services Menlo Park, California $543K AUM 174.84% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Temasek Holdings Singapore $30.5B AUM 13.98% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

HBK Investments's GH Position: Q2 2019 in Review

HBK Investments sold out of Guardant Health (GH) in Q2 2019, closing a stake of 36,403 shares — an estimated $2.79M sold.

HBK Investments first reported a position in GH in Q1 2019 and held it in 1 quarter. The position peaked at $2.79M in Q1 2019. 217 funds tracked by Wall St. Rank hold GH as of Q2 2019.

HBK Investments reported no remaining Guardant Health position as of Q2 2019 after selling out during the quarter.
HBK Investments sold 36,403 Guardant Health shares in Q2 2019, an estimated $2.79M.
HBK Investments first reported a position in Guardant Health in Q1 2019 and held it in 1 quarter.
HBK Investments's Guardant Health position peaked at $2.79M in Q1 2019.
217 funds tracked by Wall St. Rank held Guardant Health as of Q2 2019.

Based on HBK Investments's 13F filing for Q2 2019, filed 14 Aug 2019.